Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Imaflex Inc.
  6. News
  7. Summary
    IFX   CA4524352099


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Imaflex : Reports Positive Final Independent Results from ADVASEAL Efficacy Field Trial

09/11/2020 | 08:23am EST

Imaflex Inc. ('Imaflex' or the 'Corporation') (TSX-V: IFX), announces positive final independent results from the ADVASEAL Efficacy Trial, designed to determine ADVASEAL's efficacy as a fumigant replacement for field grown fresh market tomatoes in Florida.

'As we expected, the new ADVASEAL (also called 'ADVASEAL HG') containing all the active ingredients, was shown to be a viable soil fumigation alternative to the current best grower practice of using fumigants to improve yields of field grown vegetables,' said Mr. Joe Abbandonato, President and Chief Executive Officer of Imaflex. Crop yields were statistically the same, while ADVASEAL provided better weed control than fumigants. 'Not only does ADVASEAL work, it allows growers to save time and money, while transitioning towards a farming system that is more sustainable - environmentally, economically and socially.' Since there is no fumigant emission or pesticide drift, ADVASEAL should also open up acreage not currently being used due to strict buffer zone requirements associated with soil fumigation.

Study Highlights: ADVASEAL Compared With Grower Standard

Two types of the new ADVASEAL were compared, Grade A and Grade B (collectively 'ADVASEAL'), to the best grower fumigation standard. Both ADVASEAL films used the same amount of active ingredients, however they differed in coating structure. The current grower standard calls for approximately 660 pounds of a broadspectrum fumigant mixture (PIC-CLOR 60 and K-PAM 1 ) per treated acre. In comparison, ADVASEAL's clean technology uses over 95% less pesticides, resulting in lower application costs and environmental benefits. Total and marketable yields were statistically the same between treatments. Similarly, estimated gross returns, based on the average US Department of Agriculture (USDA) market value, were not significantly different between plots using ADVASEAL and those using the conventional grower standard. A numerical difference was observed for harvested tomatoes, whereby fumigated plots yielded more large tomatoes and ADAVSEAL plots yielded a greater number of extra-large tomatoes. Nutsedge (weed) control was more than 30% better with ADVASEAL versus the grower standard. Nutsedge, often called the 'world's worst weed', is an aggressive, invasive weed that can drastically reduce crop yields. Crop vigor ratings on plants and roots were good, but the grower standard was slightly more robust mid-season. However, by the end of the study whole plant and root vigor differences were not significant between treatments.

Control of root galls and nematode populations were not significantly different between the fumigated and ADVASEAL treatments. Parasitic nematodes cause irregular swelling of roots, called galls. Other symptoms of root gall include stunted growth and plant wilting. Fusarium (fungi) severity ratings on plants were not significantly different between treatments. For roots, ADVASEAL Grade B treated plots showed superior fusarium control over Grade A plots. Fusarium is a widely spread soil fungi that first infects the roots and later the plant, causing it to wilt, wither and die. 'ADVASEAL was shown to be an effective alternative to fumigants, while also bringing tangible financial and environmental advantages,' concluded Mr. Abbandonato. As a reminder, the tomato was chosen as a model plant for the trial, because it is one of the most widely grown crops in the world. Furthermore, if high tomato yields can be achieved with ADVASEAL, it can be safely assumed that high yields are also achievable for many vegetables currently requiring pre-plant soil fumigation.


Today, agricultural films are used in the growing of vegetables worldwide to cover soil treated with fumigants - volatile and toxic pesticides essential for reducing pests, weeds and fungi in the soil, thus supporting good growth of new crop seedlings. The original EPA approved ADVASEAL (ADVASEAL HSM), contained only a herbicide for weed control. The new enhanced ADVASEAL (also called 'ADVASEAL HG') under development also includes fungicides and a nematicide to control soil borne pathogens, thus becoming a complete non-fumigant alternative for soil disinfestation. With ADVASEAL, modern non-volatile crop protection products can be applied more effectively and safely than with fumigants. The crop protection products are incorporated into a coating, which is then applied to a mulch film. Once the coated film is applied to the ground the active ingredients are released into the soil under controlled conditions, preventing the over/under-dosing found with current soil disinfestation practices. This new technology dramatically reduces the amount of crop protection products required. The catalyst to trigger the release of the active ingredients is soil moisture. When the film is applied to the soil, they are efficiently and safely discharged into the ground, resulting in heightened productivity, lower costs and notable environmental benefits.

About Imaflex Inc.

Founded in 1994, Imaflex is focused on the development and manufacturing of innovative solutions for the flexible packaging space. Concurrently, the Corporation develops and manufactures films for the agriculture industry. The Corporation's products consist primarily of polyethylene (plastic) film and bags, including metalized plastic film, for the industrial, agricultural and consumer markets. Headquartered in Montreal, Page 3 of 3 Quebec, Imaflex has manufacturing facilities in Canada and the United States. The Corporation's common stock is listed on the TSX Venture Exchange under the ticker symbol IFX. Additional information is available at www.imaflex.com.

Cautionary Statement on Forward Looking Information

Certain information included in this press release constitutes 'forward-looking' statements within the meaning of Canadian securities laws. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the management of the Corporation, are inherently subject to significant business, economic and competitive uncertainties, risks and contingencies. The Corporation cautions the reader that such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual financial results, performance or achievements of Imaflex to be materially different from the Corporation's estimated future results, performance or achievements expressed or implied by those forward-looking statements and that the forward-looking statements are not guarantees of future performance. These statements are also based on certain factors and assumptions. For more details on these estimates, risks, assumptions and factors, see the Corporation's most recent Management Discussion and Analysis filed on SEDAR at www.sedar.com and on the investor section of the Corporation's website at www.imaflex.com. The Corporation disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise, except as expressly required by law. Readers are cautioned not to put undue reliance on these forward-looking statements.


Tel: (514) 935-5710

Fax: (514) 935-0264

(C) 2020 Electronic News Publishing, source ENP Newswire

All news about IMAFLEX INC.
11/24Imaflex Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Septe..
11/24Imaflex Announces Top and Bottom Line Growth for Q3 2021 and Provides Business Update
08/25Imaflex Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
08/25IMAFLEX : Announces Strong Q2 2021 Results and Provides Business Update
06/17IMAFLEX : Announces Results of Annual General Meeting of Shareholders
05/26IMAFLEX : Reports Strong Q1 2021 Results and Provides Business Update
04/15IMAFLEX : Reports Strong Q4 and FY 2020 Results and Provides Business Update
01/25IMAFLEX : Announces Positive Independent Results for the ADVASEAL« Release Study
01/25Imaflex Announces Positive Independent Results for the ADVASEAL Release Study
2020Imaflex Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
More news
Sales 2021 108 M 84,6 M 84,6 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 68,2 M 53,3 M 53,4 M
Capi. / Sales 2021 0,63x
Capi. / Sales 2022 0,66x
Nbr of Employees 222
Free-Float 54,2%
Duration : Period :
Imaflex Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Mean consensus BUY
Number of Analysts 1
Last Close Price 1,32 CAD
Average target price 1,75 CAD
Spread / Average Target 32,6%
Managers and Directors
Joseph Abbandonato Chairman, President & Chief Executive Officer
Giancarlo Santella Chief Financial Officer
Gerald R. Phelps Vice President-Operations
Michel Baril Independent Director
Philip Nolan Independent Director
Sector and Competitors
1st jan.Capi. (M$)
IMAFLEX INC.26.92%53
APTARGROUP, INC.-7.51%8 334
FP CORPORATION-11.07%2 812